|Bid||42.94 x 800|
|Ask||43.11 x 800|
|Day's Range||42.62 - 43.51|
|52 Week Range||19.46 - 44.85|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||148.80|
|Earnings Date||Feb 23, 2021 - Mar 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||43.60|
Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in November:
Avanos Medical (AVNS) continued to gain from core Chronic Care segment in the third quarter.
With me this morning are Joe Woody, CEO; and Michael Greiner, Senior Vice President. As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, economic conditions and our industry. Actual results could differ materially from those in forward-looking statements.